Cargando…

Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel coronavirus behind the fast-spreading coronavirus disease 2019 (COVID-19). Pharmaceutical researchers are currently researching medications or preventive vaccines that may be used to treat and combat the spread of COVID-19. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raphael, Vinod P., Shanmughan, Shaju K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520694/ https://www.ncbi.nlm.nih.gov/pubmed/33015628 http://dx.doi.org/10.1155/2020/8818008

Ejemplares similares

Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations
por: Lee, Ji Young, et al.
Publicado: (2019)

Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site
por: Bogoyavlenskiy, Andrey, et al.
Publicado: (2023)

In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition
por: Ničkčović, Vanja P., et al.
Publicado: (2022)

A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds
por: Saraswat, Juhi, et al.
Publicado: (2021)

Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
por: Deshmukh, Maya G., et al.
Publicado: (2021)

Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
por: Glaser, Jens, et al.
Publicado: (2022)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
por: El-Ashrey, Mohamed K., et al.
Publicado: (2022)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
por: Sivani, Bala Mohan, et al.
Publicado: (2021)

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro
por: Zhang, Leike, et al.
Publicado: (2020)

In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
por: Alesawy, Mohamed S., et al.
Publicado: (2021)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
por: Srinivasan, Vasundara, et al.
Publicado: (2022)

Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation
por: Elekofehinti, Olusola Olalekan, et al.
Publicado: (2021)

Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches
por: Santos, Esley S., et al.
Publicado: (2022)

Spectroscopic details on the molecular structure of pyrimidine‑2‑thiones heterocyclic compounds: computational and antiviral activity against the main protease enzyme of SARS-CoV-2
por: Sayed, Doaa S. El, et al.
Publicado: (2022)

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
por: Báez-Santos, Yahira M., et al.
Publicado: (2015)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease
por: Lim, Chew Theng, et al.
Publicado: (2021)

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
por: Lv, Zongyang, et al.
Publicado: (2022)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals
por: Xing, Jing, et al.
Publicado: (2021)

Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals
por: Xing, Jing, et al.
Publicado: (2021)

Natural inhibitors of SARS-CoV-2 main protease: structure based pharmacophore modeling, molecular docking and molecular dynamic simulation studies
por: Halimi, Mohammad, et al.
Publicado: (2022)

A database for the predicted pharmacophoric features of medicinal compounds
por: Daisy, Pitchai, et al.
Publicado: (2011)

Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
por: Hemmati, Seyed Ali, et al.
Publicado: (2022)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?
por: Macip, Guillem, et al.
Publicado: (2021)

Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization
por: Mercorelli, Beatrice, et al.
Publicado: (2022)

Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease
por: Moovarkumudalvan, Balasubramanian, et al.
Publicado: (2022)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
por: Zeyaullah, Md., et al.
Publicado: (2023)

Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery
por: Pathak, Nikhil, et al.
Publicado: (2020)

Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
por: Peele, K. Abraham, et al.
Publicado: (2020)

Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2
por: Mishra, Avinash, et al.
Publicado: (2022)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (M(pro)) elucidated by microsecond MD simulations
por: Hayek-Orduz, Yasser, et al.
Publicado: (2022)

Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
por: Greene-Cramer, Rebecca, et al.
Publicado: (2022)

Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors
por: Thangavel, Neelaveni, et al.
Publicado: (2022)

A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
por: Llanes, Alejandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r066g0qevcotet55h3qiqedllq